ArticleFrontiers in oncology2022

Development and Validation of a DeepSurv Nomogram to Predict Survival Outcomes and Guide Personalized Adjuvant Chemotherapy in Non-Small Cell Lung Cancer.

Bin Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.